Study Demonstrates Power of Using Ketamine for Parkinson’s Disease
by Bethan Rose
For the first time ever, researchers will conduct a comprehensive state population health analysis to understand the impact of medical cannabis on consumers’ healthcare—and it’s all happening in Arkansas. To fund the study, a $1.3 million research grant has been bestowed upon a research team at the Arkansas Center for Health Improvement (ACHI) and the University of Arkansas for Medical Sciences (UAMS), courtesy of the National Institute on Drug Abuse (NIDA).
The NIDA-funded investigation will delve into the health-related repercussions of Arkansas’ medical cannabis program, which was initially approved by voters back in 2016. The state has over 79,000 active medical marijuana ID cardholders who, reports show, have purchased more than 60,000 pounds of medical cannabis—equivalent to $400 million in transactions—since the first dispensary opened its doors in May 2019.
ACHI identifies itself as a sovereign health policy center that was formed in 1998. The nonpartisan center’s primary aim is to enhance Arkansans’ health by providing them with cooperative program development, evidence-rooted research, and social matter advocacy.
In order to understand how medical cannabis legalization has had an impact on consumer medical care in Arkansas, the researchers will merge qualifying consumers’ cannabis purchase data with information pulled from insurance claims records, among other data sources. The study will also explore the effects of the ongoing COVID-19 pandemic on the state’s program.
“This is an exciting and unique opportunity for not only our state, but also the country, to investigate the effectiveness of cannabis for therapeutic use,” said the president and CEO of ACHI, Dr. Joe Thompson. “While researchers have gathered scientific evidence on the use of cannabis for the alleviation of symptoms such as pain and anxiety, there is little evidence on how the amount, strain, potency, and method of use affect a person’s health experience.”
Thompson also serves as the study’s co-principal investigator. He will be joined by another co-principal investigator, Teresa J. Hudson, Ph.D., Pharm.D. Hudson is acknowledged as director of the Division of Health Services Research at UAMS and also maintains a position as an associate director at the VA Health Services Research and Development Center for Mental Healthcare and Outcomes Research.
A total of six data sources will be analyzed for the study, including the Arkansas Healthcare Transparency Initiative’s Arkansas All-Payer Claims Database (APCD). “The APCD is a dynamic tool that promotes transparency in healthcare data, and by combining these datasets, our state can assess specific health outcomes, including inpatient and outpatient care visits, emergency visits, opioid usage and new health diagnosis,” explained commissioner for the Arkansas Insurance Department, Alan McClain.
McClain’s department provides oversight for the Arkansas Healthcare Transparency Initiative, which supports the APCD project. According to the investigators who’ve been tasked with carrying out this study, each of the following additional sources will also ensure a more comprehensive analysis:
The state of Arkansas has raked in almost $50 million in tax revenue from medical marijuana sales since the market got into full swing in mid-2019. Of that amount, $25 million was accrued during the last nine months alone. Based on the existing law, all medical cannabis sold at the state’s licensed dispensaries is taxed at 10.5%. Of that, 4% privilege tax is provided to UAMS for the formation of a national cancer institute.
“If you walk into a dispensary and spend $100, you’ll spend $10.50 additionally in state taxes,” said Scott Hardin, who is a member of the Arkansas Medical Marijuana Commission team. He noted that the industry has been going from strength to strength during the coronavirus pandemic. “Those two taxes, we’ve collected just under $50,000,000, 49.6 million to be specific.”
The Arkansas Department of Health issued Executive Orders 20-06 and 20-16 that temporarily allowed the use of telehealth for medical cannabis certifications amid the COVID-19 pandemic. However, those orders ended on March 31, 2021. Since April 1, 2021, physicians have been forbidden from distributing medical marijuana recommendations based on an assessment conducted through telemedicine. Should this change again in the future, the state might see even higher cannabis tax revenue.
Whatever your reasons for consuming cannabis during the day, it’s important to know how your cannabis will affect you to avoid becoming couch-locked when you should be working on something. Most of society needs to get things done throughout the day, meaning that the cannabis consumed should assist, not prevent, progress. How to Pick a…
New cannabis research found that a cannabis-based drug was able to kill pancreatic cancer cells. This cannabis-based drug, or rather miraculous medication, is a botanical combination of extracts from the Cyathus striatus fungus and cannabis. This powerful combo was even able to destroy all of the cancer cells without damaging any healthy cells, unlike conventional…
Choosing the proper pot for cultivating cannabis is important. Cannabis will grow in virtually any size pot or container. Cannabis plants can be grown to maturity in a Solo cup or pots ranging from 1 gallon up to 100 gallons. There are plastic pots, and there are fabric pots. So, how do you choose which…
If you search the term “cannabis and heart health” on Google, you’ll notice that the results are flooded with pages upon pages of claims about the plant’s allegedly negative impacts on cardiovascular health. But just how true are these claims? Is the cannabis plant a true culprit for poor heart health? Well, according to a…
It’s safe to say that the wheels on the cannabis reform express have certainly been set in motion. As of April 2022, 47 states have legalized cannabis in some form or another. However, the plant’s federally illegal status—U.S. law categorizes cannabis as a Schedule I drug—means that businesses operating in this industry cannot conduct transactions with…
The U.S. State Department gave an update on WNBA star Brittney Griner’s arrest, Nevada’s ACLU warned of cops using a cannabis loophole,…
Cannabis use disorder (CUD) is often confused with frequent cannabis use, but CUD is significantly more worrisome. A recent study, funded by…
Cannabis is an incredibly versatile ingredient in the kitchen. Whether it’s dessert, dinner, or drinks, cannabis can play a fantastic role in…